Spotlight Therapeutics

General Information
Company Name
Spotlight Therapeutics
Founded Year
2017
Location (Offices)
Hayward, United States +1
Founders / Decision Makers
Number of Employees
22
Industries
Biotechnology, Health Care, Health and Wellness +1
Funding Stage
Series B
Social Media

Spotlight Therapeutics - Company Profile

Spotlight Therapeutics is an early-stage biotechnology startup that aims to revolutionize therapeutics through in vivo gene editing. Founded in December 2017 by Alex Marson (UCSF), Jacob Corn (UC Berkeley), and Patrick Hsu (Salk Institute), it has received $36.50M Series B investment from prominent investors including GV, Emerson Collective, Magnetic Ventures, EPIQ Capital Group, GordonMD Global Investments, and Team Builder Ventures. The company's focus on oncology involves using engineered nucleases to edit genes in targeted disease organs, potentially altering or deactivating the gene product. Spotlight Therapeutics is rapidly expanding its team for cutting-edge research and preclinical development, including protein engineering, gene editing, immuno-oncology, and in vivo safety studies. With its headquarters in the United States, Spotlight Therapeutics offers an opportunity to be part of the next generation of gene editing therapeutics in a dynamic and stimulating environment.

Taxonomy: Gene Editing, Therapeutics, Oncology, Research and Development, Venture Funding, In Vivo Gene Editing, Protein Engineering, Immuno-Oncology, Start-up, Early-stage, Biomedical Innovation

Funding Rounds & Investors of Spotlight Therapeutics (4)

View All
Funding Stage Amount No. Investors Investors Date
Series B $36.50M 6 22 Mar 2022
Series A $30.00M 2 30 Nov 2020
Venture Round $6.90M - 25 Sep 2019
Venture Round $7.27M - 02 Jan 2018

Latest News of Spotlight Therapeutics

View All

No recent news or press coverage available for Spotlight Therapeutics.

Similar Companies to Spotlight Therapeutics

View All
CorriXR Therapeutics - Similar company to Spotlight Therapeutics
CorriXR Therapeutics Oncology-focused biotherapeutics development company on the clinical frontier of gene editing
Reforgene Medicine - Similar company to Spotlight Therapeutics
Reforgene Medicine Innovation for Life
Hera BioLabs - Similar company to Spotlight Therapeutics
Hera BioLabs Best-in-class gene-editing and protein expression technology to reliably advance your research.
Vyriad - Similar company to Spotlight Therapeutics
Vyriad Vyriad is a clinical-stage biotech company developing targeted genetic therapies that deliver genes directly to cells.
Mammoth Biosciences - Similar company to Spotlight Therapeutics
Mammoth Biosciences Improving lives by reading and writing the code of life.